No Detail Found!

Severity of anemia during interferon and ribavirin therapy in patients with chronic active hepatitis c genotype-3 and its association with risk factors.

Author(s)
Aftab Ahmed Sheikh Department of Pharmacology, Isra University Hospital, Hyderabad, Sindh, Pakistan
Mona Humaira Department of Medicine, Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro, Sindh, Pakistan
Madiha Zaki Isra University Hospital, Hyderabad, Sindh, Pakistan
Mohammad Adnan Bawani Department of Medicine, Isra University Hospital, Hyderabad, Sindh, Pakistan
Sadik Memon Department of Medicine, Isra University Hospital, Hyderabad, Sindh, Pakistan
Abstract
Objective: Hepatitis C is a major public health problem globally. It is one of the commonest cause of chronic liver disease in Pakistan. The prevalent genotype is “3” in our country. The standard of care treatment is combination of interferon and ribavirin. This combination has important adverse effects especially hemolytic anemia. AIMS & Objectives: This study has been conducted to determine the frequency of anemia (
Publication Details
Page(s) 161-166
DOI DOI not available
Published Journal: Journal of Liaquat University of Medical and Health Sciences, Volume: 12, Issue: 3, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

33

Views